Clinical trials: Smoking Relapse Behavior
Smoking Cessation, Coronary Artery Disease
Cytisine Compared to Combination NRT in Relapsed Smokers
Cigarette smoking causes cardiovascular disease (CVD) yet many smokers with CVD are unable to quit despite strong desire to do so.
- Trial name
- CYTvsNRT+ (NCT04286295)
- Testing
- Cytisine, Nicoderm C-Q Transdermal Product, Nicorette Lozenge Product
- Where
- Canada
- Volunteers
- 13 people
- Sponsor
- Ottawa Heart Institute Research Corporation
Smoking Cessation
Smoking Cessation and Relapse Prevention in Women Postpartum
Background: Pregnancy was found to be a significant triggering factor for smoking cessation and the reduction of nicotine consumption, but 50 - 70 % of mothers who stopped smoking during pregnancy resume tobacco smoking after…
- Trial name
- EARLINT-EP3 (NCT00475046)
- Testing
- Motivational Interviewing
- Volunteers
- 2,790 people
- Sponsor
- University Medicine Greifswald
Smoking
Prevention of Postpartum Smoking Relapse in Mothers of Infants in the Neonatal Intensive Care Unit (NICU)
The investigators hypothesized that an enriched focus on mother-infant bonding during a newborn's hospitalization in the Neonatal Intensive Care Unit would reduced the rate maternal postpartum smoking relapse and would prolong…
- Trial name
- NCT01131156
- Testing
- Smoking Relapse Prevention
- Where
- United States
- Volunteers
- 54 people
- Sponsor
- Loma Linda University